BE672024A - - Google Patents

Info

Publication number
BE672024A
BE672024A BE672024DA BE672024A BE 672024 A BE672024 A BE 672024A BE 672024D A BE672024D A BE 672024DA BE 672024 A BE672024 A BE 672024A
Authority
BE
Belgium
Prior art keywords
sep
ethynyl
topical
estrogen
warm
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE672024A publication Critical patent/BE672024A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE672024D 1964-11-13 1965-11-08 BE672024A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41111964A 1964-11-13 1964-11-13

Publications (1)

Publication Number Publication Date
BE672024A true BE672024A (ja) 1966-05-09

Family

ID=23627644

Family Applications (1)

Application Number Title Priority Date Filing Date
BE672024D BE672024A (ja) 1964-11-13 1965-11-08

Country Status (4)

Country Link
BE (1) BE672024A (ja)
BR (1) BR6574657D0 (ja)
ES (1) ES319318A1 (ja)
NL (1) NL6514465A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034546A1 (ja) * 1969-02-13 1970-12-11 Organon Nv
WO2011138460A1 (en) * 2010-05-07 2011-11-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Progesterone receptor antagonists and uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792757A (en) 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034546A1 (ja) * 1969-02-13 1970-12-11 Organon Nv
WO2011138460A1 (en) * 2010-05-07 2011-11-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Progesterone receptor antagonists and uses thereof

Also Published As

Publication number Publication date
BR6574657D0 (pt) 1973-10-25
ES319318A1 (es) 1966-10-16
NL6514465A (ja) 1966-05-16

Similar Documents

Publication Publication Date Title
DE60209907T2 (de) Verwendung von oestrogenverbindungen zur steigerung der libido bei frauen
DE69433994T2 (de) Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
US4310510A (en) Self administrable anti-fertility composition
WO1999039695A1 (fr) Emulsion pour l'administration transdermique d'un principe actif
FR2884713A1 (fr) Kit steroidique et composition pouvant mousser et utilisation de ceux-ci
JP2017523138A (ja) 経皮クリーム
FR2803516A1 (fr) Formulation injectable de fulvestrant
EP1990061A2 (fr) Composition pharmaceutique pour administration transdermique ou transmuqueuse
JPH11241089A (ja) ヒトフェロモンを含有する芳香組成物および他の組成物
PL212660B1 (pl) Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie
US4048310A (en) Topical steroid formulation in form of lotion or cream
JP2008502661A (ja) 軟膏と２種の可溶化された有効成分とを含む薬剤組成物
FI88509B (fi) 9-alfa,11-beta-nitro-substituerade och 11-beta-nitro-substituerade estraner
DK2500062T3 (en) C-19 steroids to specific therapeutic applications,
JPH0395120A (ja) 局所用スピロノラクトン組成物
JP3448669B2 (ja) ラノリン脂肪酸エステル類、化粧料及び外用薬
FR2491333A1 (fr) Compositions pharmaceutiques administrables par voie topique et contenant des steroides anti-inflammatoires
CA3123301A1 (en) Nasal pharmaceutical testosterone ester gel compositions for nasal administration and method
BE672024A (ja)
EP0223671B1 (fr) Médicament à action synergétique anti-inflammatoire à base d'un corticostéroide et d'un beta-agoniste
JPH0899889A (ja) アトピー性皮膚炎治療剤
JPH0564640B2 (ja)
CA1274177A (fr) Composition pour bains a base de psoralenes dans le traitement du psoriasis
US5725803A (en) Water/oil mixed emulsifier, as well as the use thereof in cosmetic and pharmaceutical formulations
EA035300B1 (ru) Вспениваемая композиция галобетазола (варианты) и способ лечения